Primary age-related EBV-associated effusion-based lymphoma successfully treated with rituximab and thoracentesis

Justin J. Kuhlman; Muhamad Alhaj Moustafa; Alexander J. Tun; David M. Menke; Han W. Tun; Liuyan Jiang

doi:10.1002/ccr3.3971

Primary age-related EBV-associated effusion-based lymphoma successfully treated with rituximab and thoracentesis

Justin J. Kuhlman, Muhamad Alhaj Moustafa, Alexander J. Tun, David M. Menke, Han W. Tun, Liuyan Jiang

Hematology / Oncology / Cancer Center / Breast Clinic

Research output: Contribution to journal › Article › peer-review

Abstract

EBV-positive HHV8-negative EBL is part of the spectrum of EBV-positive diffuse large B-cell lymphoma NOS. This entity can be labeled as primary age-related EBV-associated EBL and appears to respond well to rituximab and thoracentesis.

Original language	English (US)
Article number	e03971
Journal	Clinical Case Reports
Volume	9
Issue number	5
DOIs	https://doi.org/10.1002/ccr3.3971
State	Published - May 2021

Keywords

EBL
EBV-positive DLBCL-NOS
EBV-positive HHV8-negative effusion-based lymphoma
aEBV-EBL
age-related EBV-associated effusion-based lymphoma

ASJC Scopus subject areas

General Medicine

Access to Document

10.1002/ccr3.3971

Cite this

@article{754e8832158f447d904604faa7e081f5,

title = "Primary age-related EBV-associated effusion-based lymphoma successfully treated with rituximab and thoracentesis",

abstract = "EBV-positive HHV8-negative EBL is part of the spectrum of EBV-positive diffuse large B-cell lymphoma NOS. This entity can be labeled as primary age-related EBV-associated EBL and appears to respond well to rituximab and thoracentesis.",

keywords = "EBL, EBV-positive DLBCL-NOS, EBV-positive HHV8-negative effusion-based lymphoma, aEBV-EBL, age-related EBV-associated effusion-based lymphoma",

author = "Kuhlman, {Justin J.} and {Alhaj Moustafa}, Muhamad and Tun, {Alexander J.} and Menke, {David M.} and Tun, {Han W.} and Liuyan Jiang",

note = "Publisher Copyright: {\textcopyright} 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.",

year = "2021",

month = may,

doi = "10.1002/ccr3.3971",

language = "English (US)",

volume = "9",

journal = "Clinical Case Reports",

issn = "2050-0904",

publisher = "John Wiley and Sons Ltd",

number = "5",

}

TY - JOUR

T1 - Primary age-related EBV-associated effusion-based lymphoma successfully treated with rituximab and thoracentesis

AU - Kuhlman, Justin J.

AU - Alhaj Moustafa, Muhamad

AU - Tun, Alexander J.

AU - Menke, David M.

AU - Tun, Han W.

AU - Jiang, Liuyan

PY - 2021/5

Y1 - 2021/5

N2 - EBV-positive HHV8-negative EBL is part of the spectrum of EBV-positive diffuse large B-cell lymphoma NOS. This entity can be labeled as primary age-related EBV-associated EBL and appears to respond well to rituximab and thoracentesis.

AB - EBV-positive HHV8-negative EBL is part of the spectrum of EBV-positive diffuse large B-cell lymphoma NOS. This entity can be labeled as primary age-related EBV-associated EBL and appears to respond well to rituximab and thoracentesis.

KW - EBL

KW - EBV-positive DLBCL-NOS

KW - EBV-positive HHV8-negative effusion-based lymphoma

KW - aEBV-EBL

KW - age-related EBV-associated effusion-based lymphoma

UR - http://www.scopus.com/inward/record.url?scp=85103562794&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85103562794&partnerID=8YFLogxK

U2 - 10.1002/ccr3.3971

DO - 10.1002/ccr3.3971

M3 - Article

AN - SCOPUS:85103562794

SN - 2050-0904

VL - 9

JO - Clinical Case Reports

JF - Clinical Case Reports

IS - 5

M1 - e03971

ER -

Primary age-related EBV-associated effusion-based lymphoma successfully treated with rituximab and thoracentesis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this